Johns Hopkins Medicine

A new Nature Medicine study identifies blood-based protein signature that could detect ALS years before symptoms. This discovery, in collaboration with the NIH, could transform early diagnosis, future treatments and clinical trial signups.

A blood test approved by the Food and Drug Administration in May provides an inexpensive and noninvasive way to detect biomarkers of Alzheimer’s disease, vastly increasing opportunities for early detection and treatment.

Cerebrovascular and endovascular neurosurgeon Risheng Xu explains chronic subdural hematoma management, including middle meningeal artery embolization, a minimally invasive procedure that has been shown to significantly reduce the chances of subdural expansion.

New NEJM study shows brain shunt surgery restores walking and reduces falls in older adults with NPH, a treatable cause of dementia-like decline affecting 1 in 13 people older than 86.

Neurologist Dr. Jessica Gill is studying biomarkers associated with TBI to learn why some patients heal more than others.

Johns Hopkins is hiring full-time CT technologists to join our team of expert radiologists, technologists, nurses and patient care coordinators to deliver high-quality imaging and compassionate patient care. Click below to apply today.